Patients' Perceptions and Patient-Reported Outcomes in Progressive-Fibrosing Interstitial Lung Diseases

European Respiratory Review - United Kingdom
doi 10.1183/16000617.0075-2018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Presentation, Diagnosis and Clinical Course of the Spectrum of Progressive-Fibrosing Interstitial Lung Diseases

European Respiratory Review
PulmonaryRespiratory Medicine
2018English

The Epidemiology of Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases at Risk of a Progressive-Fibrosing Phenotype

European Respiratory Review
PulmonaryRespiratory Medicine
2018English

Beyond Idiopathic Pulmonary Fibrosis: The World of Progressive-Fibrosing Interstitial Lung Disease

European Respiratory Review
PulmonaryRespiratory Medicine
2018English

Learning From Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Antiphospholipid Syndrome in a Patient With Rapidly Progressive Fibrosing Alveolitis.

Postgraduate Medical Journal
Medicine
1995English

PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported Outcomes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Interstitial Lung Diseases in Infants and Children

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Interstitial Lung Diseases: Course Report

Breathe
PulmonaryRespiratory Medicine
2016English

Interstitial Lung Diseases: Course Report

Breathe
PulmonaryRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy